FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

682911000001106: Histac 300mg tablets (Ranbaxy (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
15963501000001113 Histac 300mg tablets (Ranbaxy (UK) Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
15963601000001112 Histac 300mg tablets (Ranbaxy (UK) Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Histac 300mg tablets (Ranbaxy (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Histac 300mg tablets (Ranbaxy (UK) Ltd) Is a Product containing precisely ranitidine (as ranitidine hydrochloride) 300 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Histac 300mg tablets (Ranbaxy (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Histac 300mg tablets (Ranbaxy (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Histac 300mg tablets (Ranbaxy (UK) Ltd) Has active ingredient Ranitidine hydrochloride false Inferred relationship Existential restriction modifier
Histac 300mg tablets (Ranbaxy (UK) Ltd) Has active ingredient Ranitidine false Inferred relationship Existential restriction modifier
Histac 300mg tablets (Ranbaxy (UK) Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Histac 300mg tablets (Ranbaxy (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Histac 300mg tablets (Ranbaxy (UK) Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Histac 300mg tablets (Ranbaxy (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Histac 300mg tablets (Ranbaxy (UK) Ltd) Is a Histac true Inferred relationship Existential restriction modifier
Histac 300mg tablets (Ranbaxy (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Histac 300mg tablets (Ranbaxy (UK) Ltd) Has specific active ingredient Ranitidine hydrochloride true Inferred relationship Existential restriction modifier
Histac 300mg tablets (Ranbaxy (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Histac 300mg tablets (Ranbaxy (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Histac 300mg tablets (Ranbaxy (UK) Ltd) Has basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Histac 300mg tablets (Ranbaxy (UK) Ltd) 30 tablet 2 x 15 tablets Is pack of False Histac 300mg tablets (Ranbaxy (UK) Ltd) Inferred relationship Existential restriction modifier
Histac 300mg tablets (Ranbaxy (UK) Ltd) 30 tablet 2 x 15 tablets Has AMP True Histac 300mg tablets (Ranbaxy (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start